Märkte
Wertpapier | Kurs | % | Buy | Sell | Kursziel ▼ | Potential |
---|---|---|---|---|---|---|
Adamis Pharmaceuticals Corp. |
3,44 €
09.02.24 |
- | 0 | 0 | - | - |
Cumberland Pharmaceuticals |
2,44 €
18.08.21 |
-4,69 % | 0 | 0 | - | - |
Omeros Corp. |
5,00 €
23.07.24 |
7,43 % | 2 | 4 | - | - |
Vericel Corp. |
48,60 €
23.07.24 |
6,11 % | 1 | 0 | - | - |
Aveo Pharmaceuticals Inc. |
13,85 €
19.01.23 |
-1,91 % | 0 | 0 | - | - |
Endocyte Inc. |
-
- |
- | 0 | 0 | - | - |
Acelrx Pharmaceuticals Inc. |
0,77 €
23.07.24 |
-0,52 % | 0 | 0 | - | - |
Lumos Pharma Inc. |
2,06 €
21.06.24 |
1,98 % | 0 | 0 | - | - |
Chemocentryx Inc. |
53,25 €
19.10.22 |
0,57 % | 0 | 0 | - | - |
Clovis Oncology Inc. |
0,077 €
03.04.23 |
- | 0 | 0 | - | - |
Intercept Pharmaceuticals |
17,72 €
09.11.23 |
- | 0 | 0 | - | - |
Puma Biotechnology Inc. |
3,45 €
24.07.24 |
-0,06 % | 1 | 0 | - | - |
Supernus Pharmaceuticals |
27,20 €
23.07.24 |
-1,45 % | 0 | 0 | - | - |
Fortress Biotech Inc. |
0,27 €
20.11.23 |
-12,90 % | 0 | 0 | - | - |
Medicinova Inc. |
3,22 €
30.09.21 |
-0,16 % | 0 | 0 | - | - |
Epizyme Inc. |
1,43 €
02.12.22 |
- | 0 | 0 | - | - |
Chembio Diagnostics Inc. |
0,41 €
05.08.23 |
- | 0 | 0 | - | - |
Organovo Holdings Inc. |
0,53 €
24.07.24 |
-2,07 % | 0 | 8 | - | - |
Five Prime Therapeutics |
31,60 €
24.07.21 |
- | 0 | 0 | - | - |
MEI Pharma Inc. |
4,38 €
22.07.23 |
- | 6 | 0 | - | - |
Veracyte Inc. |
22,00 €
18.07.24 |
-2,59 % | 1 | 0 | - | - |
Merrimack Pharmaceuticals Inc. |
3,98 €
30.09.21 |
-0,50 % | 0 | 0 | - | - |
Aerie Pharmaceuticals Inc. |
14,80 €
03.03.23 |
- | 0 | 0 | - | - |
Sorrento Therapeutics Inc. |
0,28 €
16.06.23 |
- | 0 | 0 | - | - |
Biospecifics Techs |
73,00 €
02.12.20 |
-0,68 % | 0 | 0 | - | - |
Assembly Biosciences Inc. |
0,93 €
09.02.24 |
3,99 % | 0 | 0 | - | - |
Dicerna Pharmaceuticals Inc. |
33,75 €
02.04.22 |
- | 0 | 0 | - | - |
Genocea Biosciences Inc. |
0,009 €
23.12.22 |
- | 1 | 21 | - | - |
Revance Therapeutics Inc. |
3,64 €
24.07.24 |
-9,00 % | 0 | 1 | - | - |
Concert Pharmaceuticals Inc. |
7,88 €
19.06.23 |
- | 0 | 0 | - | - |